Achilles Therapeutics plc Quarterly Entity Common Stock, Shares Outstanding from Q4 2021 to Q4 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Achilles Therapeutics plc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2021 to Q4 2023.
  • Achilles Therapeutics plc Entity Common Stock, Shares Outstanding for the quarter ending December 31, 2023 was 41.1M shares, a 0.37% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 41.1M +150K +0.37% Dec 31, 2023 20-F 2024-04-04
Q4 2022 40.9M +329K +0.81% Dec 31, 2022 20-F 2023-03-07
Q4 2021 40.6M Dec 31, 2021 20-F 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.